[Intravenous morphazinamide. Tolerance of the drug and therapeutic effects].
D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D004654:Empyema, Tuberculous / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D011719:Pyrazines / Q000008:administration & dosage / Q000009:adverse effects; D014391:Tuberculosis, Miliary / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D011719:Pyrazines
Morfazinamide per via venosa. Tolleranza del farmaco ed effetti terapeutici.